The excitement surrounding the dipeptide Carnosine began when researchers at the Commonwealth Scientific and Industrial Research Organization (CSIRO), Australia’s premier scientific research center painstakingly documented the unthinkable: that carnosine can not only slow down, but actually reverse, cellular senescence – the process of “aging” at the cellular level.
Based on their results, scientists “propose that carnosine is an important component of cellular maintenance mechanisms,” and “favor the view that it may have a very important role in controlling cellular homeostasis” – that is, in keeping cells in the tightly-regulated condition that optimizes their function.
The results of the many human trials constitute proof-of-concept for the wider concept that the use of topical Carnosine – and especially the unique Carnosine metabolite N-Acetyl-L-Carnosine, a biological “delivery system” for Carnosine – can help the eyes to heal from damage, and allow the body to remove dysfunctional proteins from the eye.
